During the gene therapy trial, they slowed the disease’s progress in 75 percent of cases, allowing patients to live potentially decades longer with a better quality of life.

Credits: iStock;

The condition rapidly kills brain cells and is usually fatal within two decades of symptoms revealing themselves, affecting an estimated 75,000 people in the UK alone.